Affiliation:
1. Microbiology Unit, Canterbury Health Laboratories, Christchurch, New Zealand
2. Department of Pathology, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand
Abstract
ABSTRACT
Streptococcus pseudopneumoniae
is a recently described streptococcus that is phenotypically and genetically distinct from
Streptococcus pneumoniae
and other viridans streptococci. Key characteristics of
S. pseudopneumoniae
are the absence of a pneumococcal capsule, insolubility in bile, resistance or indeterminate susceptibility to optochin when incubated in 5% CO
2
but susceptibility to optochin when incubated in ambient air, and a positive reaction with the AccuProbe DNA probe hybridization test. The clinical importance of this bacterium is currently unknown. We report the characteristics and associated clinical data of 35 strains of
S. pseudopneumoniae
isolated from sputum samples from 33 patients. All isolates produced a positive result with the NOW
S. pneumoniae
antigen test (Binax, Inc.). No isolate was resistant to penicillin, but 60% were resistant to erythromycin and 77% were resistant to tetracycline. All patients had lower respiratory tract symptoms, 79% had chronic obstructive pulmonary disease (COPD), and 33% had chest radiographic infiltrates. Compared with matched control patients who had
Streptococcus pneumoniae
isolated from sputum, patients with
S. pseudopneumoniae
infection were more likely to have a history of COPD (odds ratio [OR], 5.0; 95% confidence interval [CI], 1.67 to 20.11) or exacerbation of COPD (OR, 6.5; 95% CI, 2.61 to 16.20). Further research is needed to better characterize the epidemiology of
S. pseudopneumoniae
colonization and the role of
S. pseudopneumoniae
in COPD and other diseases.
Publisher
American Society for Microbiology
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献